Human neutralizing antibodies against MERS coronavirus: implications for future immunotherapy
- PMID: 26098703
- PMCID: PMC5068219
- DOI: 10.2217/imt.15.33
Human neutralizing antibodies against MERS coronavirus: implications for future immunotherapy
Keywords: IGHV1–69; MERS-CoV; animal model; biodefense; emerging pathogen; human monoclonal antibodies; humoral immunity; passive immunotherapy; spike protein; zoonosis.
References
-
- Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 2012;367(19):1814–1820. - PubMed
-
- WHO Global Alert and Response (GAR): Middle East respiratory syndrome coronavirus (MERS-CoV) – Qatar. 2015 Mar 11; www.who.int/csr/don/11-march-2015-mers-qatar/en.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources